Google Finance: notícies i preu de les accions del tíquer Incyte Corp (INCY)

Pàgina d'iniciINCY • NASDAQ

Incyte Corp

103,84 $

21 de gen., 13:49:53 GMT-5 · USD · NASDAQ · Exempció de responsabilitat

Tancament anterior

102,62 $

Interval de preus d'avui

101,00 $ - 103,93 $

Interval anual

53,56 $ - 112,29 $

Capitalit. borsària

20,39 kM USD

Volum mitjà

2,18 M

Ràtio preu-benefici

17,56

Rendibilitat per dividend

Borsa principal

NASDAQ

Notícies dels mercats

Investor's Business Daily

fa 2 hores

Stock Market Today: Dow Jumps On Trump Assurance; Berkshire Hathaway Eyes $7 Billion Sale (Live Coverage)

Axios

fa 8 hores

Trump 2.0 stock market underperforms Trump 1.0

CNBC

fa 7 minuts

Stocks recover from sell-off after Trump rules out military action on Greenland: Live updates

MarketWatch

fa 20 hores

These stocks were the biggest losers on the S&P 500’s worst day in three months

This electronics maker crushed earnings. It’s one of the S&P 500’s top stocks today.

The NYSE's big tokenization plan is nothing but vaporware says a Columbia business professor

Informació

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia

Conseller delegat, CO

Hervé Hoppenot

Data de fundació

2002

Seu principal

Wilmington, Delaware
Estats Units d'Amèrica

Lloc web

incyte.com

Empleats

2.617